Harbor Advisors’s Gilead Sciences GILD Stock Holding History

Harbor Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$253K	Hold	2,000	–	–	0.03%	171
2026 Q1	$279K	Hold	2,000	–	–	0.04%	162
2025 Q4	$245K	Hold	2,000	–	–	0.04%	169
2025 Q3	$222K	Hold	2,000	–	–	0.03%	168
2025 Q2	$222K	Hold	2,000	–	–	0.04%	170
2025 Q1	$224K	Buy	+2,000	New	+$206K	0.04%	175
2021 Q1	–	Sell	-6,000	Closed	-$350K	–	201
2020 Q4	$350K	Hold	6,000	–	–	0.08%	107
2020 Q3	$379K	Hold	6,000	–	–	0.09%	87
2020 Q2	$462K	Buy	6,000 +2,000	+50%	+$153K	0.12%	77
2020 Q1	$299K	Hold	4,000	–	–	0.09%	88
2019 Q4	$260K	Hold	4,000	–	–	0.07%	136
2019 Q3	$254K	Hold	4,000	–	–	0.07%	139
2019 Q2	$270K	Hold	4,000	–	–	0.08%	137
2019 Q1	$260K	Sell	4,000 -3,000	-43%	-$199K	0.08%	139
2018 Q4	$438K	Hold	7,000	–	–	0.17%	89
2018 Q3	$540K	Hold	7,000	–	–	0.17%	88
2018 Q2	$496K	Hold	7,000	–	–	0.16%	89
2018 Q1	$528K	Hold	7,000	–	–	0.18%	82
2017 Q4	$501K	Hold	7,000	–	–	0.17%	87
2017 Q3	$567K	Hold	7,000	–	–	0.21%	73
2017 Q2	$495K	Hold	7,000	–	–	0.2%	75
2017 Q1	$475K	Hold	7,000	–	–	0.2%	68
2016 Q4	$501K	Buy	+7,000	New	+$520K	0.24%	71

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbor Advisors's GILD Position: Q2 2026 in Review

Harbor Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,000 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #171.

Harbor Advisors first reported a position in GILD in Q4 2016 and has held it in 23 quarters since. The position peaked at $567K in Q3 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Harbor Advisors held 2,000 shares of Gilead Sciences worth $253K as of Q2 2026.
Harbor Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.03% of Harbor Advisors's portfolio in Q2 2026, its #171 holding.
Harbor Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 23 quarters since.
Harbor Advisors's Gilead Sciences position peaked at $567K in Q3 2017.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Harbor Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.